Cargando…

Clinically relevant reductions in HbA(1c) without hypoglycaemia: results across four studies of saxagliptin

BackgroundIn four 24-week controlled studies, the antihyperglycaemic efficacy of saxagliptin was demonstrated in patients with type 2 diabetes mellitus as add-on therapy to glyburide, a thiazolidinedione, or metformin, and when used in initial combination with metformin vs. metformin monotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Karyekar, C S, Frederich, R, Ravichandran, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842088/
https://www.ncbi.nlm.nih.gov/pubmed/23795975
http://dx.doi.org/10.1111/ijcp.12212

Ejemplares similares